TD Asset Management’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-194,026
Closed -$1.13M – 1269
2026
Q2
$1.13M Sell
194,026
-144,800
-43% -$960K ﹤0.01% 1070
2026
Q1
$2.46M Buy
338,826
+86,666
+34% +$1.13M ﹤0.01% 923
2025
Q4
$4.29M Buy
252,160
+109,752
+77% +$1.12M ﹤0.01% 827
2025
Q3
$1.04M Sell
142,408
-37,200
-21% -$301K ﹤0.01% 1084
2025
Q2
$1.17M Buy
179,608
+25,200
+16% +$166K ﹤0.01% 1040
2025
Q1
$1.25M Sell
154,408
-161,798
-51% -$1.77M ﹤0.01% 1047
2024
Q4
$3.91M Buy
316,206
+64,400
+26% +$860K ﹤0.01% 842
2024
Q3
$2.09M Buy
251,806
+67,860
+37% +$406K ﹤0.01% 1021
2024
Q2
$918K Sell
183,946
-68,000
-27% -$388K ﹤0.01% 1178
2024
Q1
$1.55M Buy
251,946
+46,200
+22% +$231K ﹤0.01% 1084
2023
Q4
$1.04M Buy
205,746
+43,054
+26% +$230K ﹤0.01% 1175
2023
Q3
$935K Buy
+162,692
New +$743K ﹤0.01% 1160
2021
Q1
– Sell
-51,234
Closed -$403K – 1550
2020
Q4
$403K Buy
+51,234
New +$430K ﹤0.01% 1359

Other funds holding WVE

TD Asset Management's WVE Position: Q3 2026 in Review

TD Asset Management sold out of Wave Life Sciences (WVE) in Q3 2026, closing a stake of 194,026 shares — an estimated $1.13M sold.

TD Asset Management first reported a position in WVE in Q4 2020 and held it in 13 quarters. The position peaked at $4.29M in Q4 2025. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • TD Asset Management reported no remaining Wave Life Sciences position as of Q3 2026 after selling out during the quarter.
  • TD Asset Management sold 194,026 Wave Life Sciences shares in Q3 2026, an estimated $1.13M.
  • TD Asset Management first reported a position in Wave Life Sciences in Q4 2020 and held it in 13 quarters.
  • TD Asset Management's Wave Life Sciences position peaked at $4.29M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.